Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 15Lymphoid 7Breast 5Thoracic 4Genitourinary 4Dermatologic 4Sarcoma 2Plasma cell 2Other solid neoplasm 2Other hematologic neoplasm 2Head & Neck 2CNS 2Tumor-Agnostic 1Other neoplasm 1Myeloid 1Gynecologic 1

Conditions

Pleural Effusion, Malignant 2Mesothelioma, Malignant 2

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Pharmaceutical Preparations × Other solid neoplasm × Clear all
NCT07443020 2026-04-07

RIOT 4B

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07192900 2026-01-15

(RIOT 4A)

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡